| Name | Title | Contact Details |
|---|---|---|
Caithlin Kapsner |
Assistant Director of Technology | Profile |
Samuel Yamoah |
Chief Innovation Officer | Profile |
Chris Bryant |
Director of IT Operations | Profile |
Lisa Hartford |
Director Security Risk Management | Profile |
Michel Romanino |
Director of Security Risk Management and Deputy Chief Information Security Officer | Profile |
Medical Facilities holds controlling interest in five specialty surgical hospitals located in Arkansas, Indiana, Oklahoma, and South Dakota. Medical Facilities` hospitals focus on a limited number of high volume, non-emergency surgical, diagnostic and imaging procedures. The case mix at each hospital is a function of the clinical specialties of the physicians on the medical staff and the equipment and infrastructure at each facility. Orthopedic and neurosurgical procedures represent a large portion of the case volumes at the hospitals. Medical Facilities also holds interest in ambulatory surgery centers located in Arkansas, California, Michigan, Missouri, Nebraska, Ohio, Oregon and Pennsylvania. The centers perform a broad range of outpatient procedures, with patient stays of less than 24 hours.
BDF is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lerman and Son Orthotics and Prosthetics is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bid Prep is a Aliso Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.